Vaccine Study Center Archives

No serious side effects for mRNA COVID-19 vaccines in young children

June 6, 2023

A review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children (most of them age 4 and younger) found no indications of serious side effects.

COVID-19 vaccination was effective in children, adolescents during 2021

April 7, 2023

A large study of U.S. children and teens who received the Pfizer/BioNTech COVID-19 vaccine finds that it was effective through much of 2021, but waned over time, especially as the omicron variant became dominant in 2022. Teens who received a booster dose regained some protection.

COVID-19 vaccination of mother during pregnancy protects infant, though protection wanes

February 28, 2023

Being vaccinated against COVID-19 during pregnancy provides protection for the baby through its first several months of life, a Kaiser Permanente analysis finds. Protection was stronger against the delta variant than the more recent omicron variant.

Study offers reassurance to pregnant patients using biologic medications for autoimmune disorders

June 9, 2022

A new study led by Kaiser Permanente researchers provides reassurance about vaccinating infants whose mothers took biologic medications for an autoimmune disorder during pregnancy.

Lower in-hospital mortality for vaccinated patients hospitalized with COVID-19

May 9, 2022

COVID-19 patients in Kaiser Permanente Northern California hospitals during the delta surge of 2021 were less likely to die in the hospital of COVID-19 if they were vaccinated, new research finds.

No serious health effects linked to mRNA COVID-19 vaccines

September 3, 2021

Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.

COVID-19 vaccine trial enrolls children aged 5-11 at 3 sites in Northern California

June 9, 2021

About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.

Kaiser Permanente data key to nation’s COVID-19 vaccine surveillance strategy

January 6, 2021

Kaiser Permanente’s Vaccine Study Center is leading a key part of the national safety surveillance effort for the COVID-19 vaccines, tracking patient data for serious side effects.

It’s flu season: What you need to know about the research

October 9, 2020

What does it take to be sure the annual flu vaccine is effective and safe? Research. In a podcast, Nicola Klein, head of the Vaccine Study Center, tackles some common questions about the vaccine and recent findings.

Study identifies geographic clusters of pregnant women who missed flu shots

September 8, 2020

A Kaiser Permanente analysis of women who did not get flu shots during their pregnancies found the women clustered in geographic “hot spots.” These women tended to have fewer prenatal medical visits and live in low-income neighborhoods.

Q&A: Talking Flu Shots with Nicola Klein, Director of Kaiser Permanente’s Vaccine Study Center

September 19, 2018

Dr. Klein’s latest research raised some interesting questions about when influenza vaccinations are most effective, so we spoke with her to learn more and answer some common flu vaccine questions.

Research Spotlight

Categories